4D Molecular Therapeutics
FDMT
#8483
Rank
NZ$0.25 B
Marketcap
$5.58
Share price
-0.75%
Change (1 day)
-86.31%
Change (1 year)

EPS for 4D Molecular Therapeutics (FDMT)

EPS in 2023 (TTM): -$5.37

According to 4D Molecular Therapeutics's latest financial reports the company's current EPS (TTM) is -$5.52. In 2022 the company made an earnings per share (EPS) of -$5.59 a decrease over its 2021 EPS that were of -$4.31.

EPS history for 4D Molecular Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$5.37-3.91%
2022-$5.5929.69%
2021-$4.31-15.82%
2020-$5.12

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$3.67-33.54%๐Ÿ‡บ๐Ÿ‡ธ USA